{"symbol":"BMY","fiscalQuarter":"Q1-2012","reportDate":"2012-04-26","reportTime":"BMO","status":"reported","company":{"name":"Bristol-Myers Squibb Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BMY/earnings/Q1-2012","postBrief":{"headline":"Bristol Myers Squibb Beats on EPS \u2014 Stock Down 1.55%","keyNumbers":[{"metric":"EPS","actual":"$0.64","expected":"N/A","surprise":"+5.09%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS performance this quarter.","Our focus remains on delivering value through our pipeline."],"summary":"Management expressed satisfaction with the EPS results, highlighting the company's commitment to its product pipeline. However, they did not provide specific guidance for future quarters."},"guidanceChanges":{"summary":"No forward guidance was provided in this earnings report.","changes":[]},"whatItMeans":"Bristol Myers Squibb's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 1.55%. This drop may reflect investor concerns over the lack of revenue data and future guidance, which could impact confidence in the company's growth prospects.","metaDescription":"Bristol Myers Squibb (BMY) Q1 2012 earnings: EPS beat expectations. Stock down 1.55%. Full breakdown."}}